Cancer biomarkers such as BRCA1/2 are significant indicators of breast cancer; however, many BRCA1/2 mutations and unknown genetic variants are poorly defined, making disease risk uncertain and disease assessment and diagnosis complicated [2,27]. This evidence concerns the gene BRCA1 and breast carcinoma.